Disease Synopsis
Drugs and Clinical Candidates
Clinical Trials (visual)
Clinical Trials (text)
Cell Line Models

Brain Tumour - Overview - Disease Synopsis

Drugs & Clinical Candidates

6 drugs have received FDA approval for Brain Tumour . Bevacizumab, Carmustine, Dexamethasone Sodium Phosphate, Everolimus, Lomustine and Temozolomide
334 drugs have a clinical trial registered for Brain Tumour.

Sources: cancer.gov and clinicaltrials.gov
(see details)

Clinical Trials

There are 1624 clinical trials for Brain Tumour,
983 of which have one or more drug interventions,
641 with no drug intervention.

Sources: cancer.gov and clinicaltrials.gov
(see details)

Cell Line Models

There are 188 Cell Line Models for Brain Tumour.

Source: COSMIC
(see details)


There are 2825 Compounds which have been tested in Brain Tumour , 1942 <= 500nM potency.

Source: ChEMBL
(see details)


Please note the mappings below are based on an imperfect algorithm. If you notice any anomalies please report them to us.

The following terms have been mapped from clinicaltrials.gov mesh condition terms to Brain Tumour:
Brain Neoplasms
Brain Stem Neoplasms
Skull Base Neoplasms

The following terms have been mapped from cancer.gov to Brain Tumour:
Brain tumors. It is used in patients who have already had surgery or radiation therapy
Anaplastic astrocytoma
Brain tumors (certain types)
Cerebral edema (fluid build-up in the brain)
Glioblastoma (a type of brain cancer). It is used in adults whose:Cancer has recurred. This use is approved for the Avastin brand of bevacizumab
Glioblastoma multiforme (GBM)
Glioblastoma multiforme that has recurred (come back). It is used with surgery
Subependymal giant cell astrocytoma in adults and children aged 1 year or older who have tuberous sclerosis and are not able to have surgery